Strive International Developed Mkts ETF STXI

Medalist Rating as of | See Strive Asset Management Investment Hub

Morningstar’s Analysis STXI

Will STXI outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Strive International Developed Mkts ETF’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings STXI

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 16.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk AS Class B

2.65 381,039
Healthcare

ASML Holding NV

2.21 317,208
Technology

Nestle SA

1.75 251,213
Consumer Defensive

Novartis AG Registered Shares

1.65 236,778
Healthcare

AstraZeneca PLC

1.60 230,176
Healthcare

SAP SE

1.57 225,378
Technology

Roche Holding AG

1.48 213,306
Healthcare

Shell PLC

1.44 207,178
Energy

Lvmh Moet Hennessy Louis Vuitton SE

1.29 186,130
Consumer Cyclical

Toyota Motor Corp

1.27 183,136
Consumer Cyclical

Sponsor Center